» Articles » PMID: 37256475

STOPP/START Criteria for Potentially Inappropriate Prescribing in Older People: Version 3

Abstract

Purpose: STOPP/START is a physiological systems-based explicit set of criteria that attempts to define the clinically important prescribing problems relating to potentially inappropriate medications (PIMs-STOPP criteria) and potential prescribing omissions (PPOs-START criteria). The previous two versions of STOPP/START criteria were published in 2008 and 2015. The present study describes the revised and updated third version of the criteria.

Methods: A detailed system-by-system review of the published literature from April 2014 to March 2022 was undertaken with the aim of including clinically important new explicit PIM and PPO criteria and removing any criteria considered to be no longer correct or outdated. A panel of 11 academic physicians with recognized expertise in geriatric pharmacotherapy from 8 European countries participated in a Delphi panel with the task of validating the draft criteria. The panel was presented with the draft new criteria using the SurveyMonkey® on-line platform in which panelists were asked to indicate their level of agreement on a five-point Likert scale.

Results: Two hundred and four evidence-based draft criteria (one hundred and forty-five STOPP criteria, fifty-nine START criteria) were presented to panelists for assessment using the Delphi validation method. Over the course of four rounds of Delphi validation, the panel achieved consensus on 133 STOPP criteria and 57 START criteria, i.e., 190 STOPP/START criteria in total representing a 66.7% increase in the number of criteria compared to STOPP/START version 2 published in 2015.

Conclusion: A fully revised and updated version of STOPP/START criteria has been validated by a European expert panel using the Delphi consensus process.

Citing Articles

Emergency Department Programs to Support Medication Safety in Older Adults: A Systematic Review and Meta-Analysis.

Skains R, Hayes J, Selman K, Zhang Y, Thatphet P, Toda K JAMA Netw Open. 2025; 8(3):e250814.

PMID: 40067297 PMC: 11897843. DOI: 10.1001/jamanetworkopen.2025.0814.


Protocol to evaluate the feasibility of the D-PRESCRIBE intervention adapted to the Belgian community setting (END-IT CS study).

Petein C, Chevallereau T, Aikpitanyi J, Evrard P, Tubeuf S, Henrard S BMJ Open. 2025; 15(3):e085434.

PMID: 40037665 PMC: 11891543. DOI: 10.1136/bmjopen-2024-085434.


Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians.

Shapoval V, de Saint Hubert M, Evrard P, Sibille F, Aubert C, Bolt L JAMA Netw Open. 2025; 8(3):e2459883.

PMID: 40029661 PMC: 11877185. DOI: 10.1001/jamanetworkopen.2024.59883.


Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.

Boccardi V, Bahat G, Balci C, Bourdel-Marchasson I, Christiaens A, Donini L Eur Geriatr Med. 2025; .

PMID: 40014274 DOI: 10.1007/s41999-025-01168-1.


The Effects of Remimazolam and Inhalational Anesthetics on the Incidence of Postoperative Hyperactive Delirium in Geriatric Patients Undergoing Hip or Femur Surgery Under General Anesthesia: A Retrospective Observational Study.

Kim J, Lee S, Yoo B, Lim Y, Jun I Medicina (Kaunas). 2025; 61(2).

PMID: 40005452 PMC: 11857627. DOI: 10.3390/medicina61020336.


References
1.
He J, Morales D, Guthrie B . Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic review. Trials. 2020; 21(1):228. PMC: 7045589. DOI: 10.1186/s13063-020-4139-0. View

2.
OMahony D, Gudmundsson A, Soiza R, Petrovic M, Cruz-Jentoft A, Cherubini A . Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2020; 49(4):605-614. DOI: 10.1093/ageing/afaa072. View

3.
Pazan F, Weiss C, Wehling M . The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging. 2018; 35(1):61-71. DOI: 10.1007/s40266-017-0514-2. View

4.
Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991; 151(9):1825-32. View

5.
OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View